Dynamic contrast enhanced magnetic resonance imaging

• US 20040242994A1
• Filed: 07/14/2004
• Published: 12/02/2004
• Est. Priority Date: 07/13/2001
• Status: Abandoned Application

• Current Assignee: Mirada Solutions Ltd. (Siemens AG)
• Original Assignee: Mirada Solutions Ltd. (Siemens AG)
• Inventors: Armitage, Paul Anthony, Brady, John Michael, Behrenbruch, Christian Peter
• Application Number:
  US10/483,705
• Publication Number:
  US 20040242994A1
• Time in Patent Office: Days
• US Class Current: 600/420
• CPC Class Codes: G01R 33/56 Image enhancement or correction, e.g. subtraction or averaging techniques , e.g. improvement of signal-to-noise ratio and resolution
• CPC Class Codes: G01R 33/5601 involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Abstract

A method of dynamic contrast enhanced magnetic resonance imaging, and of processing the signals from such imaging, in order to improve the characterisation of tissue types being imaged. A calculation of the longitudinal relaxation time T₁ is made for each voxel in the image by applying pulse sequences having different flip angles or TRs and fitting the resulting resonance signals to a model of the imaging process. Dynamic, contrast-enhanced imaging is then conducted and by using the T₁ values the results may be fitted to a pharmacokinetic model of the uptake of contrast agent in the tissue being imaged. This gives values for physiological parameters relating to the permeability of the tissue and the extravascular extracellular space volume fraction. These, together with the T₁ value provide an excellent characterisation of the tissue as malignant or benign. The parameters may be displayed using a vector map or by displaying each of them in a different colour, allowing a quick and meaningful of the image to be made.

Claims

1. :

A method of enhancing a dynamic contrast-enhanced magnetic resonance image comprising the steps of;

for each voxel of the image fitting to the magnetic resonance signal a parameterised pharmaco-kinetic model of the contrast enhancement process in the sample being imaged to calculate the values of parameters of the model which represent properties of the imaged sample,

and displaying the image with each of said parameters being represented in a visually distinguishable manner.

2. :

A method according to claim 1 wherein the parameters are each represented by a different colour whose intensity is representative of the value of the parameter.

3. :

A method according to claim 1 wherein the parameters for each of a plurality of regions of the sample are represented as components of a vector displayed for each region.

4. :

A method according to claim 3 wherein at least one of the parameters is represented by the intensity or colour of the displayed vector.

5. :

A method according to claim 1 wherein the parameters are represented in a relative phase coherence map.

6. :

A method according to claim 1 wherein the parameters include at least one parameter representative of the physiology of the imaged sample.

7. :

A method according to claim 6 wherein the at least one parameter representative of the physiology of the imaged sample is at least one of;

the extravascular extracellular space (EES) volume fraction, and the permeability surface area product per unit volume of the sample (K^trans).

8. :

A method according to claim 1 wherein the parameters include at least one parameter representative of the structure of the imaged sample.

9. :

A method according to claim 8 wherein the at least one parameter representative of the structure of the imaged sample is the longitudinal relaxation time (T₁).

10. :

A method according to claim 1 wherein the parameterised pharmaco-kinetic model is a two- or three-compartment pharmaco-kinetic model.

22. :

A method according to claim 1 wherein the sample is soft tissue in the human or animal body.

23. :

A method according to claim 1 wherein the sample is a human breast.

24. :

Magnetic resonance imaging apparatus comprising a data processor and a display, the data processor being adapted to calculate the values of parameters of the model which represent properties of the imaged sample, and the display being operable to display the parameters, in accordance with the method of claim 1.

25. :

Magnetic resonance imaging apparatus according to claim 24 further comprising a controller for causing the application to the sample of successive electromagnetic pulse sequences, each sequence having a different flip angle, the data processor being adapted to calculate from the resonance signals the longitudinal relaxation time (T₁) for the sample, by the steps of;

acquiring resonance signals by applying to a subject successive electromagnetic pulse sequences, each sequence differing in a selected acquisition parameter,

and calculating from the resonance signals the longitudinal relaxation time (T₁) for the sample.

26. :

A computer program comprising program code means for executing on programmed data processing apparatus according to the method of claim 1.

11. :

A method of magnetic resonance imaging comprising the steps of;

acquiring resonance signals by applying to a subject successive electromagnetic pulse sequences, each sequence differing in a selected acquisition parameter,

and calculating from the resonance signals the longitudinal relaxation time (T₁) for the sample.

12. :

A method according to claim 11 wherein the selected acquisition parameter which differs from sequence to sequence is the flip angle.

13. :

A method according to claim 11 wherein the selected acquisition parameter which differs from sequence to sequence is the repetition time (TR).

14. :

A method according to claim 12 wherein the selected acquisition parameter is varied from sequence to sequence to minimise the error in the longitudinal relaxation time (T₁) over the range expected in the sample, such as, by example the Monte Carlo simulation/method.

15. :

A method according to claim 11 wherein the pulse sequence is a gradient echo sequence.

16. :

A method according to claim 15 wherein the pulse sequence is a T₁ weighted 3D fast spoiled gradient echo sequence.

17. :

A method according to claim 11 wherein the longitudinal relaxation time (T₁) is calculated by fitting the resonance signals for the successive sequences to a model of the sample'"'"'s response to the pulse sequence.

18. :

A method according to claim 17 wherein the model includes correction for non-uniform excitation across the sample.

19. :

A method according to claim 17 wherein the model includes correction for bias field (B₁) inhomogeneity across the sample.

20. :

A method according to claim 11 wherein the longitudinal relaxation time (T₁) is calculated for each voxel of the sample.

21. :

A method according to claim 11, further comprising applying a contrast agent and further electromagnetic pulse sequences to the sample to produce a dynamic contrast-enhanced magnetic resonance image, and enhancing the image by the steps of;

for each voxel of the image fitting to the magnetic resonance signal a parameterised pharmaco-kinetic model of the contrast enhancement process in the sample being imaged to calculate the values of parameters of the model which represent properties of the imaged sample,

and displaying the image with each of said parameters being represented in a visually distinguishable manner.